Skip to Content

Sarepta Therapeutics

SRPT

Buy $SRPT at eToro
Rank 1962
Country USA
Exchange NASDAQ
Currency USD
Sector LIFE SCIENCES
Industry PHARMACEUTICAL PREPARATIONS
Address 215 FIRST STREET, SUITE 415, CAMBRIDGE, MA, US

Sarepta Therapeutics - Key figures

Market cap 5.77 Billion
Revenue 701.89 Million
Profit -165,844,000
P/E Ratio No information
P/s Ratio 8.22
Buy $SRPT at eToro

Sarepta Therapeutics - Description

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapies, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases.

The company is headquartered in Cambridge, Massachusetts.